Trivarx Ltd has released a press release.
FDA Strategy and Regulatory Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Appendix 4E and Annual Report
- MEB Appoints R&CPMK As Communications Agency in the US
- Medibio strengthens its IP protection
- Re-submission of FDA 510(k) application
- Consumer Mental Health App Development - Second Test Phase
Later from TrivarX
- MEB to Raise up to $5.7 million by way of a Placement & NREO
- Non-Renounceable Entitlement Offer Underwriting Update
- Termination of Underwriting Agreement
- Medibio Announces Entitlement Offer Result
- FDA Confirm Diagnostic Method on Depression Validation Trial
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX